Carcinogenesis Advance Access originally published online on May 13, 2006
Carcinogenesis 2006 27(6):1121-1125; doi:10.1093/carcin/bgl033
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ANTHONY DIPPLE CARCINOGENESIS AWARD WINNER |
The necessity of a human epigenome project
Director, Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain
Tel: +34 91 2246940; Fax: +34 91 2246923; Email: mesteller{at}cnio.es
Epigenetics is one of the hottest topics in cancer research. We know that human tumors undergo a major disruption of their DNA methylation and histone modification patterns. The aberrant epigenetic landscape of the cancer cell is characterized by a massive genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor genes, an altered histone code for critical genes and a global loss of monoacetylated and trimethylated histone H4. But what we know is just a minimal percentage of the epigenetic ‘earthquake’ present in the transformed cell. We need to make an ambitious step to understand the DNA methylation and histone changes underlying tumorigenesis. The launching of an International Human Epigenome Project should be the response to this necessity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 547 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hadnagy, R. Beaulieu, and D. Balicki Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics Mol. Cancer Ther., April 1, 2008; 7(4): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T M Murphy, A S Perry, and M Lawler The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 11 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Martin Epigenomics and disease, 10th anniversary winter meeting of the UK Molecular Epidemiology Group (MEG), The Royal Statistical Society, London, UK, 8th December 2006 Mutagenesis, November 1, 2007; 22(6): 425 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Barlesi, G. Giaccone, M. I. Gallegos-Ruiz, A. Loundou, S. W. Span, P. Lefesvre, F. A.E. Kruyt, and J. A. Rodriguez Global Histone Modifications Predict Prognosis of Resected Non Small-Cell Lung Cancer J. Clin. Oncol., October 1, 2007; 25(28): 4358 - 4364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vineis and F. Perera Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1954 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Coolen, A. L. Statham, M. Gardiner-Garden, and S. J. Clark Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements Nucleic Acids Res., September 25, 2007; 35(18): e119 - e119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A Ross and J. A Milner Epigenetic modulation and cancer: effect of metabolic syndrome? Am. J. Clinical Nutrition, September 1, 2007; 86(3): 872S - 877S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller Epigenetic gene silencing in cancer: the DNA hypermethylome Hum. Mol. Genet., April 15, 2007; 16(R1): R50 - R59. [Abstract] [Full Text] [PDF]
|
|